FindTrial
Sign In

The application of gene mutation and molecular diagnosis of thyroid nodules in Chinese population, a multi-center research

The application of gene mutation and molecular diagnosis of thyroid nodules in Chinese population, a multi-center research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087574
Enrollment
Unknown
Registered
2024-07-30
Start date
2023-02-01
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid nodules

Interventions

Gold Standard:postoperative paraffin pathology
Index test:NGS-18 gene test, PCR-8 gene test

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1: Patients who were diagnosed as thyroid nodules in the five research center from January 1, 2021 to December 31, 2022 2: Patients who received preoperative or postoperative NGS-18/ PCR-8 gene test for thyroid nodules 3:Age=18 years old

Exclusion criteria

Exclusion criteria: 1: Patients who suffered from a secondary primary cancer at the same time 2: Patients with the history of other malignant tumors for less than 5 years

Design outcomes

Primary

MeasureTime frame
Sensitivities, Sen;Specificities, Spe;Positive predictive values, PPV;Negative predictive values, NPV;—

Countries

China

Contacts

Public ContactJian Fei

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

fj10777@rjh.com.cn+86 189 1670 3777

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026